References
- Abu-Raddad, L., Chemaitelly, H., Ayoub, H., AlMukdad, S., Yassine, H., Al-Katib, H., … Al-Kanaani, Z. (2022). Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar. New England Journal of Medicine, (online early view). doi:10.1056/NEJMoa2200797
- Allen, D. (2022). COVID-19 lockdown cost/benefits: A critical assessment of the literature. International Journal of the Economics of Business, 29(1), 1–32.
- Auld, C., & Toxvaerd, F. (2021). The great COVID-19 vaccine rollout: Behavioral and policy responses. National Institute Economic Review, 257(1), 14–35.
- Benn, C., Schaltz-Buchholzer, F., Nielsen, S., Netea, M., & Aaby, P. (2022). Randomised clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects? Preprints with the Lancet. doi:10.2139/ssrn.4072489
- Bjørnskov, C. (2021). Did lockdown work? An economist’s cross-country comparison. CESifo Economic Studies, 67(3), 318–331.
- Brewer, N. (2021). What works to increase vaccination uptake? Academic Pediatrics, 21(4), S9–S16.
- Cohn, B., Cirillo, P., Murphy, C., Krigbaum, N., & Wallace, A. (2022). SARS-CoV-2 vaccine protection and deaths among US veterans during 2021. Science, 375(6578), 331–336.
- Cooke, H. (2021, August 13). Border-opening trial this year, vaccine speed-up. The Dominion Post. https://www.pressreader.com/new-zealand/the-dominion-post/20210813/281689732877170.
- Creighton, A. (2021, July 20). Suppression plans straight from CCP play book. The Australian. https://www.theaustralian.com.au/commentary/suppression-plans-straight-from-ccp-play-book/news-story/71242afe71048b13dd88fe3f4c2fafd9.
- Doshi, P. (2020). Will COVID-19 vaccines save lives? Current trials aren’t designed to tell us. BMJ, 371, m4037.
- Doshi, P. (2021, August 23). Does the FDA think these data justify the first full approval of a Covid-19 vaccine. BMJ Opinion. https://blogs.bmj.com/bmj/2021/08/23/does-the-fda-think-these-data-justify-the-first-full-approval-of-a-covid-19-vaccine/
- Doshi, P., Godlee, F., & Abbasi, K. (2022). COVID-19 vaccines and treatments: We must have raw data, now. BMJ, 376, o102.
- Doshi, P., & Kaplan, R. (2021). Inaccurate statement. JAMA, 325, 1039.
- Gibson, J. (2022a). Government mandated lockdowns do not reduce COVID-19 deaths: Implications for evaluating the stringent New Zealand response. New Zealand Economic Papers, 56(1), 17–28.
- Gibson, J. (2022b). Hard, not early: Putting the New Zealand COVID-19 response in context. New Zealand Economic Papers, 56(1), 1–8.
- Gibson, J., McKenzie, D., & Stillman, S. (2013). Accounting for selectivity and duration-dependent heterogeneity when estimating the impact of emigration on incomes and poverty in sending areas. Economic Development & Cultural Change, 61(2), 247–280.
- Godlee, F. (2020). COVID-19: Less haste, more safety. BMJ, 370, m3258.
- Heatley, D. (2022). A social cost–benefit framework for COVID-19 policy decisions. New Zealand Economic Papers, 56(1), 41–48.
- Imai, C., Toizumi, M., Hall, L., Lambert, S., Halton, K., & Merollini, K. (2018). A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers. PloS one, 13(6), e0198685.
- Karaivanov, A., Kim, D., Lu, S., & Shigeoka, H. (2021). COVID-19 vaccination mandates and vaccine uptake. Working Paper 29563, National Bureau of Economic Research.
- Lally, M. (2021a). A cost-benefit analysis of Covid-19 vaccine mandates. mimeo https://www.wgtn.ac.nz/__data/assets/pdf_file/0011/1983899/r-covid-vaccine-mandates.pdf.
- Lally, M. (2021b). The costs and benefits of COVID-19 lockdowns in New Zealand. medRxiv. doi:10.1101/2021.07.15.21260606
- Macdonald, N. (2021, September 14). Covid-19: To boost or not to boost? The Press. https://www.stuff.co.nz/national/health/coronavirus/126331885/covid19-to-boost-or-not-to-boost.
- MacNamara, K. (2021, November 2). The suffocating spin of NZ’s vaccine taskforce. New Zealand Herald. https://www.nzherald.co.nz/business/kate-macnamara-the-suffocating-spin-of-nzs-vaccine-taskforce/YGMWBQ53GRTUVLLK3TFDW5ZMVQ/.
- Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., … Rodés-Guirao, L., (2021). A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(1), 947–953.
- McKenzie, D., Gibson, J., & Stillman, S. (2007). Moving to opportunity, leaving behind what? Evaluating the initial effects of a migration policy on incomes and poverty in source areas. New Zealand Economic Papers, 41(2), 197–223.
- McKenzie, D., Gibson, J., & Stillman, S. (2010). How important is selection? Experimental vs. non-experimental measures of the income gains from migration. Journal of the European Economic Association, 8(4), 913–945.
- McKenzie, P. (2022, January 10). New Zealand not prepared for Omicron outbreak expected in ‘matter of weeks’, experts warn. The Guardian. https://www.theguardian.com/world/2022/jan/10/new-zealand-not-prepared-for-omicron-outbreak-expected-in-matter-of-weeks-experts-warn.
- Meslé, M., Brown, J., Mook, P., Hagan, J., Pastore, R., Bundle, N., … Dykhanovska, T. (2021). Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European region, December 2020 to November 2021. Eurosurveillance, 26(1), 2101021.
- Mills, M., & Rüttenauer, T. (2022). The effect of mandatory COVID-19 certificates on vaccine uptake: Synthetic-control modelling of six countries. The Lancet Public Health, 7(1), 15–22.
- Neil, M., Fenton, N., Smalley, J., Craig, C., Guetzkow, J., McLachlan, S., … Rose, J. (2022). Official mortality data for England suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of COVID-19 vaccination. Working Paper QMUL. doi:10.13140/RG.2.2.28055.09124
- Németh, L., Jdanov, D., & Shkolnikov, V. (2021). An open-sourced, web-based application to analyse weekly excess mortality based on the short-term mortality fluctuations data series. PloS One, 16(2), e0246663.
- Nordström, P., Ballin, M., & Nordström, A. (2022). Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: A retrospective, total population cohort study in Sweden. The Lancet, 399(10327), 814–823.
- Sachdeva, S. (2022, April 22). Defence Force staff face dismissal over vaccine mandate. Newsroom. https://www.newsroom.co.nz/defence-force-staff-face-dismissal-over-vaccine-mandate.
- Tartof, S., Slezak, J., Fischer, H., Hong, V., Ackerson, B., Ranasinghe, O., … McLaughlin, J. (2021). Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. The Lancet, 398(10309), 1407–1416.
- Walensky, R., Walke, H., & Fauci, A. (2021). SARS-CoV-2 variants of concern in the United States – challenges and opportunities. JAMA, 325, 1037.
- Weekes, J. (2022, April 14). Covid 19 Omicron: Orange day dawns after curve flattened and return to office looms for many. New Zealand Herald. https://www.nzherald.co.nz/nz/politics/covid-19-omicron-orange-day-dawns-after-curve-flattened-and-return-to-office-looms-for-many.
- White, E., Yang, X., Blackman, C., Feifer, R. A., Gravenstein, S., & Mor, V. (2021). Incident SARS-CoV-2 infection among mRNA-vaccinated and unvaccinated nursing home residents. New England Journal of Medicine, 385(5), 474–476.
- Witton, B. (2021). Coronavirus: Vaccine hesitancy will fade as more information comes to light – experts. The Press, February 2. https://www.stuff.co.nz/national/health/coronavirus/124119830/coronavirus-vaccine-hesitancy-will-fade-as-more-information-comes-to-light–experts.